Skip to main content
Premium Trial:

Request an Annual Quote

Waters, Advion Finish Evaluating Integration of Synapt MS With NanoMate Infusion Tech

NEW YORK (GenomeWeb News) — Waters and Advion Biosciences have completed the evaluation phase of a product-integration effort and have kicked off a co-marketing campaign this week at the LC-MS Montreux Symposium in Switzerland, Waters said.
The companies are integrating Advion’s TriVersa NanoMate infusion technology with Waters’ Synapt high definition mass spectrometer into a platform that Waters said will help researchers maximize the information they can pull from large quantities of samples.
An Advion spokesperson said the products will be interoperable in three to six months.
Waters’ Synapt can probe the size and shape of ions, while Advion’s NanoMate makes it easier to maintain the “native conformation of protein or peptide ions into the gas phase,” which the company said also increases reproducibility.
Waters said the integrated product will be used to “analyze monoclonal antibodies, multi-protein and protein-ligand complexes, top down proteomics and metabolite identification."

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.